Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: synthesis, biological investigation and molecular modeling studies.

[1]  C. Pannecouque,et al.  Synthesis and Anti‐HIV Activity of Aryl‐2‐[(4‐cyanophenyl)amino]‐4‐pyrimidinone hydrazones as Potent Non‐nucleoside Reverse Transcriptase Inhibitors , 2011, ChemMedChem.

[2]  Youcef Mehellou,et al.  Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go? , 2010, Journal of medicinal chemistry.

[3]  Peng Zhan,et al.  Design strategies of novel NNRTIs to overcome drug resistance. , 2009, Current medicinal chemistry.

[4]  M. Radi,et al.  Towards novel S-DABOC inhibitors: synthesis, biological investigation, and molecular modeling studies. , 2008, Bioorganic & medicinal chemistry letters.

[5]  A. Mai,et al.  5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones, a series of anti-HIV-1 agents of the dihydro-alkoxy-benzyl-oxopyrimidine family with peculiar structure-activity relationship profile. , 2008, Journal of medicinal chemistry.

[6]  Maurizio Botta,et al.  A Multidisciplinary Approach for the Identification of Novel HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors: S‐DABOCs and DAVPs , 2008, ChemMedChem.

[7]  G. Maga,et al.  Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants. , 2007, Journal of medicinal chemistry.

[8]  A. Mai,et al.  Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains. , 2007, Journal of medicinal chemistry.

[9]  Jan Balzarini,et al.  Synthesis and Anti-HIV-1 Activity Evaluation of 5-Alkyl-2-alkylthio-6-(arylcarbonyl or α-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors , 2007 .

[10]  E. Crespan,et al.  Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity. , 2005, Journal of medicinal chemistry.

[11]  Bart De Corte,et al.  From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2005 .

[12]  Silvio Massa,et al.  Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant. , 2004, Journal of medicinal chemistry.

[13]  J. Tronchet,et al.  Nonnucleoside inhibitors of HIV-1 reverse transcriptase: from the biology of reverse transcription to molecular design. , 2003, Current topics in medicinal chemistry.

[14]  E. De Clercq,et al.  Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors. , 2002, Molecular pharmacology.

[15]  E. Novellino,et al.  5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives. , 1999, Journal of medicinal chemistry.

[16]  R. Haugland,et al.  Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation. , 1997, Analytical biochemistry.

[17]  Richard T. Walker,et al.  Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. , 1996, Journal of medicinal chemistry.

[18]  A. Mai,et al.  Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines. , 1995, Journal of medicinal chemistry.

[19]  A. Mai,et al.  3,4-Dihydro-2-Alkoxy-6-Benzyl-4-Oxopyrimidines (DABOs): A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 , 1993 .

[20]  H. Koroniak,et al.  FACILE LARGE SCALE SYNTHESIS OF 5-ALKYLURACILS , 1993 .

[21]  M. Botta,et al.  Synthesis, antimicrobial and antiviral activities of isotrimethoprim and some related derivatives , 1992 .

[22]  R. Gallo,et al.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.

[23]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[24]  E. De Clercq,et al.  Dihydro-alkoxyl-benzyl-oxopyrimidine derivatives (DABOs) as non-nucleoside reverse transcriptase inhibitors: an update review (2001-2011). , 2012, Current medicinal chemistry.

[25]  C. Pannecouque,et al.  Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later , 2008, Nature Protocols.